Clinical trial Recruiting at 1 site Interventional Ages 45 to 74 Women only

Early diagnosis of lung cancer in Korean women

Official title: A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females Who Are Never Smoker with a Family History of Lung Cancer

Run by Samsung Medical Center · NCT06181929 · Data updated 2026-11-12

This study is testing a new way to find lung cancer early in Korean women aged 45-74 who have never smoked and have a family history of the disease.

More Health Risk Behaviors trials

Quick facts

Study typeInterventional
Ages45 Years to 74 Years
SexWomen only
Enrollment200 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedJune 1, 2024
Main results expectedMay 31, 2026
Study endsMay 31, 2034
Registry record updatedMarch 5, 2025
Trial IDNCT06181929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Korean females aged 45-74, who have never smoked and have a family history of lung cancer.

Probably not a fit

Patients with a prior history of lung cancer or those currently exhibiting symptoms suggestive of lung cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm prospective pilot study aimed at early lung cancer diagnosis in Korean females aged 45-74 who have never smoked and have a family history of lung cancer. The study will enroll 200 participants over two years, who will undergo low-dose CT (LDCT) screenings and blood draws for plasma-based assays. Participants with positive screening results will receive further diagnostic evaluations, while those with negative results will have repeat LDCT exams for two additional years. A medical history questionnaire will also be administered to assess risk factors.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection of lung cancer in high-risk Korean women, potentially improving treatment outcomes.

How similar studies have gone: Other studies have shown success with similar LDCT screening approaches for lung cancer detection, particularly in high-risk populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 45-74 years old
2. Korean female
3. Never smoker defined as a lifetime exposure of less than 100 cigarettes
4. Family history of lung cancer at first degree relatives (parents, siblings, or children)

Exclusion Criteria:

1. Prior history of lung cancer.
2. Diagnosis of any cancer within the past five years
3. Participation in a cancer prevention trial.
4. Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis.
5. Medical or psychiatric condition precluding informed medical consent.
6. History of LDCT screening, chest CT, PET or PET/CT scan within 10 years

Where it's running

  • Samsung Medical Center
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.